154 related articles for article (PubMed ID: 35052737)
21. Tissue distribution of S-(2-succino)cysteine (2SC), a biomarker of mitochondrial stress in obesity and diabetes.
Thomas SA; Storey KB; Baynes JW; Frizzell N
Obesity (Silver Spring); 2012 Feb; 20(2):263-9. PubMed ID: 22134201
[TBL] [Abstract][Full Text] [Related]
22. Down-regulation of the expression of the obese gene by an antidiabetic thiazolidinedione in Zucker diabetic fatty rats and db/db mice.
Zhang B; Graziano MP; Doebber TW; Leibowitz MD; White-Carrington S; Szalkowski DM; Hey PJ; Wu M; Cullinan CA; Bailey P; Lollmann B; Frederich R; Flier JS; Strader CD; Smith RG
J Biol Chem; 1996 Apr; 271(16):9455-9. PubMed ID: 8621615
[TBL] [Abstract][Full Text] [Related]
23. Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity.
Buchanan J; Mazumder PK; Hu P; Chakrabarti G; Roberts MW; Yun UJ; Cooksey RC; Litwin SE; Abel ED
Endocrinology; 2005 Dec; 146(12):5341-9. PubMed ID: 16141388
[TBL] [Abstract][Full Text] [Related]
24. Ciglitazone, a new hypoglycaemic agent. 4. Effect on pancreatic islets of C57BL/6J-ob/ob and C57BL/KsJ-db/db mice.
Diani AR; Peterson T; Sawada GA; Wyse BM; Gilchrist BJ; Hearron AE; Chang AY
Diabetologia; 1984 Aug; 27(2):225-34. PubMed ID: 6386585
[TBL] [Abstract][Full Text] [Related]
25. Cardiac fibroblast-dependent extracellular matrix accumulation is associated with diastolic stiffness in type 2 diabetes.
Hutchinson KR; Lord CK; West TA; Stewart JA
PLoS One; 2013; 8(8):e72080. PubMed ID: 23991045
[TBL] [Abstract][Full Text] [Related]
26. Temporal relationship of tissue somatostatin-like immunoreactivity to metabolic changes in genetically obese and diabetic mice.
Berelowitz M; Coleman DL; Frohman LA
Diabetes; 1980 Sep; 29(9):717-23. PubMed ID: 6108273
[TBL] [Abstract][Full Text] [Related]
27. Of mice and mutations: phenotypic effects of the diabetic db/db and ob/ob mutations on the skull and teeth of mice.
Atar M; Yasmin R; Sharma R; Le Comber SC; Verry P; Polly PD
Eur Arch Paediatr Dent; 2008 Mar; 9(1):37-40. PubMed ID: 18328237
[TBL] [Abstract][Full Text] [Related]
28. Targeted proteomics effectively quantifies differences between native lung and detergent-decellularized lung extracellular matrices.
Calle EA; Hill RC; Leiby KL; Le AV; Gard AL; Madri JA; Hansen KC; Niklason LE
Acta Biomater; 2016 Dec; 46():91-100. PubMed ID: 27693690
[TBL] [Abstract][Full Text] [Related]
29. Ovarian hypercytolipidemia induced by obese (ob/ob) and diabetes (db/db) mutations: basis of female reproductive tract involution II.
Garris DR
Tissue Cell; 2004 Jun; 36(3):157-69. PubMed ID: 15140593
[TBL] [Abstract][Full Text] [Related]
30. The effect of ponalrestat on sorbitol levels in the lens of obese and diabetic mice.
Vicario PP; Slater EE; Saperstein R
Biochem Int; 1989 Sep; 19(3):553-61. PubMed ID: 2510726
[TBL] [Abstract][Full Text] [Related]
31. Enhanced Nrf2 activity worsens insulin resistance, impairs lipid accumulation in adipose tissue, and increases hepatic steatosis in leptin-deficient mice.
Xu J; Kulkarni SR; Donepudi AC; More VR; Slitt AL
Diabetes; 2012 Dec; 61(12):3208-18. PubMed ID: 22936178
[TBL] [Abstract][Full Text] [Related]
32. Vascular Mechanics in Decellularized Aortas and Coronary Resistance Microvessels in Type 2 Diabetic db/db Mice.
Anghelescu M; Tonniges JR; Calomeni E; Shamhart PE; Agarwal G; Gooch KJ; Trask AJ
Ann Biomed Eng; 2015 Nov; 43(11):2760-70. PubMed ID: 25986954
[TBL] [Abstract][Full Text] [Related]
33. Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice.
Chow FY; Nikolic-Paterson DJ; Ma FY; Ozols E; Rollins BJ; Tesch GH
Diabetologia; 2007 Feb; 50(2):471-80. PubMed ID: 17160673
[TBL] [Abstract][Full Text] [Related]
34. The relationship of tissue localization, distribution and turnover to feeding after intraperitoneal 125I-leptin administration to ob/ob and db/db mice.
Van Heek M; Mullins DE; Wirth MA; Graziano MP; Fawzi AB; Compton DS; France CF; Hoos LM; Casale RL; Sybertz EJ; Strader CD; Davis HR
Horm Metab Res; 1996 Dec; 28(12):653-8. PubMed ID: 9013736
[TBL] [Abstract][Full Text] [Related]
35. Genetic control of organ-reactive autoantibody production in mice by obesity (ob) diabetes (db) genes.
Yoon JW; Leiter EH; Coleman DL; Kim MK; Pak CY; McArthur RG; Roncari DA
Diabetes; 1988 Sep; 37(9):1287-93. PubMed ID: 3044893
[TBL] [Abstract][Full Text] [Related]
36. Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury.
Aroor AR; Das NA; Carpenter AJ; Habibi J; Jia G; Ramirez-Perez FI; Martinez-Lemus L; Manrique-Acevedo CM; Hayden MR; Duta C; Nistala R; Mayoux E; Padilla J; Chandrasekar B; DeMarco VG
Cardiovasc Diabetol; 2018 Jul; 17(1):108. PubMed ID: 30060748
[TBL] [Abstract][Full Text] [Related]
37. Gene expression profiles of nondiabetic and diabetic obese mice suggest a role of hepatic lipogenic capacity in diabetes susceptibility.
Lan H; Rabaglia ME; Stoehr JP; Nadler ST; Schueler KL; Zou F; Yandell BS; Attie AD
Diabetes; 2003 Mar; 52(3):688-700. PubMed ID: 12606510
[TBL] [Abstract][Full Text] [Related]
38. Reno-protection of G004, a novel anti-diabetic sulfonylurea in db/db mice.
Tong X; Ma H; Amadi SW; Ma L; Wu G
Naunyn Schmiedebergs Arch Pharmacol; 2015 Aug; 388(8):831-41. PubMed ID: 25943026
[TBL] [Abstract][Full Text] [Related]
39. Expression levels of enzymes generating NO and CO in islets of murine and human diabetes.
Mohammed Al-Amily I; Lundquist I; Salehi A
Biochem Biophys Res Commun; 2019 Dec; 520(2):473-478. PubMed ID: 31607476
[TBL] [Abstract][Full Text] [Related]
40. Glucose, insulin, insulin receptor subunits α and β in normal and spontaneously diabetic and obese ob/ob and db/db infertile mouse testis and hypophysis.
Pelletier RM; Layeghkhavidaki H; Vitale ML
Reprod Biol Endocrinol; 2020 Mar; 18(1):25. PubMed ID: 32183843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]